Microbial systems have become the preferred testing grounds for experimental work on the evolution of traits that benefit other group members. This work, based on conceptual and theoretical models of frequency-dependent selection within populations, has proven fruitful in terms of understanding the dynamics of group beneficial or ‘public goods’ traits
within species
. Here, we expand the scope of microbial work on the evolution of group-beneficial traits to the case of
multi-species communities
, particularly those that affect human health. We examined whether β-lactamase-producing
Escherichia coli
could protect ampicillin-sensitive cohorts of other species, particularly species that could cause human disease. Both β-lactamase-secreting
E. coli
and, surprisingly, those engineered to retain it, allowed for survival of a large number of ampicillin-sensitive cohorts of
Salmonella enterica
serovar Typhimurium, including both laboratory and clinical isolates. The
Salmonella
survivors, however, remained sensitive to ampicillin when re-plated onto solid medium and there was no evidence of gene transfer.
Salmonella
survival did not even require direct physical contact with the resistant
E. coli
. The observed phenomenon appears to involve increased release of β-lactamase from the
E. coli
when present with
S. enterica
. Significantly, these findings imply that resistant
E. coli
, that are not themselves pathogenic, may be exploited, even when they are normally selfish with respect to other
E. coli
. Thus,
Salmonella
can gain protection against antibiotics from
E. coli
without gene transfer, a phenomenon not previously known. As a consequence, antibiotic-resistant
E. coli
can play a decisive role in the survival of a species that causes disease and may thereby interfere with successful treatment.